Open AccessRhinocerebral Mucormycosis in a COVID-19 Patient from Nepal: A Case Report
Author(s) -
Sanjay Kumar Gupta,
Pallawi Jyotsana,
Avilasha Singh,
Diwakar Phuyal,
Parbej Allam
Publication year - 2021
Publication title -
journal of nepal medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.176
H-Index - 19
eISSN - 1815-672X
pISSN - 0028-2715
DOI - 10.31729/jnma.6904
Subject(s) - medicine , mucormycosis , surgery , magnetic resonance imaging , sinus (botany) , debridement (dental) , radiology , botany , biology , genus
With the surge of cases during the second wave of COVID-19 in Nepal, a number of mucormycosis coinfection cases have also come to our attention. We present a case of a 65-year-old female who was admitted to our emergency department with complaints of pain, swelling, and tingling sensation of the left side of the face along with blood-tinged nasal discharge for 20 days. She had been tested positive for COVID-19 a month back and managed with oxygen support and corticosteroids. Magnetic Resonance Imaging showed invasive fungal sinusitis, with the positive black turbinate sign and mild extension along with the dura mater of the left temporal lobe, and left cavernous sinus. She was diagnosed with rhinocerebral mucormycosis and managed with systemic antifungal therapy and insulin. As per the treatment modality, surgical debridement could not be done because the patient did not give consent.